Anonymous ID: 33991a April 24, 2024, 7:08 a.m. No.20770200   🗄️.is đź”—kun

>>20769905

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268563/

 

Analysis of health outcomes in vaccinated and unvaccinated children: Developmental delays, asthma, ear infections and gastrointestinal disorders

 

Results:

Vaccination before 1 year of age was associated with increased odds of developmental delays (OR = 2.18, 95% CI 1.47–3.24), asthma (OR = 4.49, 95% CI 2.04–9.88) and ear infections (OR = 2.13, 95% CI 1.63–2.78). In a quartile analysis, subjects were grouped by number of vaccine doses received in the first year of life. Higher odds ratios were observed in Quartiles 3 and 4 (where more vaccine doses were received) for all four health conditions considered, as compared to Quartile 1. In a temporal analysis, developmental delays showed a linear increase as the age cut-offs increased from 6 to 12 to 18 to 24 months of age (ORs = 1.95, 2.18, 2.92 and 3.51, respectively). Slightly higher ORs were also observed for all four health conditions when time permitted for a diagnosis was extended from ⩾ 3 years of age to ⩾ 5 years of age.

 

Conclusion:

In this study, which only allowed for the calculation of unadjusted observational associations, higher ORs were observed within the vaccinated versus unvaccinated group for developmental delays, asthma and ear infections. Further study is necessary to understand the full spectrum of health effects associated with childhood vaccination.

Anonymous ID: 33991a April 24, 2024, 7:12 a.m. No.20770208   🗄️.is đź”—kun

>>20769905

https://pubmed.ncbi.nlm.nih.gov/33266457/

 

Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination (Retracted)

 

Abstract

We performed a retrospective analysis spanning ten years of pediatric practice focused on patients with variable vaccination born into a practice, presenting a unique opportunity to study the effects of variable vaccination on outcomes. The average total incidence of billed office visits per outcome related to the outcomes were compared across groups (Relative Incidence of Office Visit (RIOV)). RIOV is shown to be more powerful than odds ratio of diagnoses. Full cohort, cumulative incidence analyses, matched for days of care, and matched for family history analyses were conducted across quantiles of vaccine uptake. Increased office visits related to many diagnoses were robust to days-of-care-matched analyses, family history, gender block, age block, and false discovery risk. Many outcomes had high RIOV odds ratios after matching for days-of-care (e.g., anemia (6.334), asthma (3.496), allergic rhinitis (6.479), and sinusitis (3.529), all significant under the Z-test). Developmental disorders were determined to be difficult to study due to extremely low prevalence in the practice, potentially attributable to high rates of vaccine cessation upon adverse events and family history of autoimmunity. Remarkably, zero of the 561 unvaccinated patients in the study had attention deficit hyperactivity disorder (ADHD) compared to 0.063% of the (partially and fully) vaccinated. The implications of these results for the net public health effects of whole-population vaccination and with respect for informed consent on human health are compelling. Our results give agency to calls for research conducted by individuals who are independent of any funding sources related to the vaccine industry. While the low rates of developmental disorders prevented sufficiently powered hypothesis testing, it is notable that the overall rate of autism spectrum disorder (0.84%) in the cohort is half that of the US national rate (1.69%). The practice-wide rate of ADHD was roughly half of the national rate. The data indicate that unvaccinated children in the practice are not unhealthier than the vaccinated and indeed the overall results may indicate that the unvaccinated pediatric patients in this practice are healthier overall than the vaccinated.

Anonymous ID: 33991a April 24, 2024, 8:40 a.m. No.20770629   🗄️.is đź”—kun

>>20770594

I see fire.

 

https://www.reuters.com/business/finance/russian-court-orders-seizure-jpmorgan-chase-funds-vtb-lawsuit-2024-04-24/

Russian court orders seizure of JPMorgan Chase funds in VTB lawsuit

 

MOSCOW, April 24 (Reuters) - A Russian court has ordered the seizure of funds in JPMorgan , opens new tab bank accounts in Russia, court filings showed on Wednesday, in a lawsuit filed by state-owned bank VTB (VTBR.MM), opens new tab as it seeks to regain funds blocked abroad.

JP Morgan Chase last week sued VTB in New York to halt its efforts to recover $439.5 million from an account that was blocked after Russia despatched its army to Ukraine in 2022 and VTB was hit with sanctions.

JPMorgan Chase declined to comment on the Russian court's interim measures. VTB did not immediately comment on Wednesday. It has previously declined to comment on its legal disputes with JPMorgan Chase.

The Arbitration Court of St Petersburg and the Leningrad Region's ruling was dated April 22.

The court said it had ordered the seizure of all funds in JP Morgan bank accounts in Russia, including correspondent accounts and those opened in the name of a subsidiary. The court said it had not seized securities and property held by JP Morgan funds, or the jpmorgan.ru domain.

In a complaint filed in federal court in Manhattan earlier this month, JPMorgan described VTB's attempt to recover the money in Russia as a "blatant breach" of its agreement to have disputes addressed in New York.

The largest U.S. bank said U.S. law prohibits it from releasing the $439.5 million, and VTB, Russia's second-largest bank, will try to seize its assets abroad if it prevails in the Russia lawsuit.

It said VTB's prospects there were good, with Russian courts having granted at least six other Russian banks relief against U.S. and European banks that were required to comply with sanctions laws.